Clinical Trials in Boston

Showing 8721-8740 of 17,836 trials

COMPLETEDNA< 1 mile

Disseminating an Evidence-based Tobacco Control Intervention for School Teachers in India

NCT05346991

Disseminating an evidence-based tobacco control intervention for School Teachers

Tobacco Use Cessation

Glorian Sorensen1,102 participantsStarted Jun 2018

Boston, Massachusetts, United States • Mumbai, India

COMPLETEDPhase 2< 1 mile

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

NCT00126672

This research study is evaluating a drug called rapamycin as a possible treatment for the lumps (or tumors) that form in the kidneys, called angiomyolipomas, in people who have either TSC or LAM. Kidney angiomyolipomas are tumors that are made up of blood vessels, muscle and fat. Rapamycin has been approved to treat other diseases, but it is investigational for treating kidney angiomyolipomas. Investigational means that it is being as a possible treatment for kidney angiomyolipomas but is not currently approved by the U.S. Food and Drug Administration (FDA) for treating this disease.

Nonmalignant NeoplasmTuberous SclerosisLymphangioleimyomatosis+1 more

Dana-Farber Cancer Institute36 participantsStarted Dec 2005

Loma Linda, California, United States • Hartford, Connecticut, United States • Boston, Massachusetts, United States +4 more locations

Disseminating an Evidence-based Tobacco Control Intervention for School Teachers in India

RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

Find Trials by Condition in Boston

Tau/P-Tau and Neurocognitive Outcomes in Children

Safety and Tolerability of WVE-120102 in Patients With Huntington's Disease

Testing Feasibility of Motivational Interviewing for Patient-Reported Cancer Pain Goals

A Study of the Efficacy and Safety of Hematopoietic Stem Cells Transduced With Lenti-D Lentiviral Vector for the Treatment of Cerebral Adrenoleukodystrophy (CALD)

Evaluating the Infectivity, Safety, and Immunogenicity of Recombinant Live-Attenuated RSV Vaccines RSV ΔNS2/Δ1313/I1314L or RSV 276 in RSV-Seronegative Infants 6 to 24 Months of Age

Compare Efficacy/Safety of Repeat Doses of Ferumoxytol With Iron Sucrose in CKD Subjects With IDA and on Hemodialysis

Convalescent Plasma to Stem Coronavirus (CSSC-001)

Integrase and Maraviroc Intensification in Neurocognitive Dysfunction (InMIND)

Effect of AMR101 (Ethyl Icosapentate) on Triglyceride (Tg) Levels in Patients on Statins With High Tg Levels (≥ 200 and < 500 mg/dL)

Efficacy Study of Arbaclofen to Treat Spasticity in Multiple Sclerosis

BRAVO Study: Laquinimod Double-blind Placebo-controlled Study in Participants With Relapsing-Remitting Multiple Sclerosis (RRMS) With a Rater Blinded Reference Arm of Interferon β-1a (Avonex®)

An Extension Study in Participants With Moderate to Severe Rheumatoid Arthritis

One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity

Ph 1-2 Study ADI-PEG 20 Plus FOLFOX in Subjects With Advanced GI Malignancies Focusing on Hepatocellular Carcinoma

Study Comparing the Efficacy and Safety of Insulin Glargine (Basal Insulin)/Lixisenatide (GLP-1 Receptor Agonist) Combination (Soliqua™) in Patients With Type 2 Diabetes Mellitus (T2DM)

Efficacy and Safety of AMR101 (Ethyl Icosapentate) in Patients With Fasting Triglyceride (Tg) Levels ≥ 500 and ≤ 2000 mg/dL

The ADAPT Study: Assessment of the DiAgnostic Performance of DeepVessel FFR in SuspecTed Coronary Artery Disease

Twelve -Month Study Observing How Insulin-naïve Patients With Type 2 Diabetes Mellitus Manage Diabetes Using Toujeo® After Oral Antidiabetic Drug Failure, the Side Effect of Toujeo®, and The Cost.